SharifA., BaboolalK.Risk factors for new-onset diabetes after kidney transplantation. Nat Rev Nephrol2010; 6: 415–23.
2.
BurroughsT.E.. Diabetic complications associated with new-onset diabetes mellitus after transplant recipients. Transplantation2007; 83: 1027–34.
3.
Van HooffJ.R., ChristiaansM.H., van DuijnhovenE.M.Evaluating mechanisms of post-transplant diabetes mellitus. Nephrol Dial Transplant2004; 19(Suppl 6): vi8–vi12.
4.
KasiskeB., SnyderJ.J., GilberstonD.. Diabetes mellitus after Kidney transplantation in the United States. Am J Transplant2003; 3: 178–85.
5.
KamarN., MariatC., DelahousseM.. Diabetes mellitus after Kidney transplantation: a French multicentre observational study. Nephrol Dial Transplant2007; 22: 1986–93.
6.
HjelmesaethJ., MidtvedK., JenssenT.. Insulin resistance after renal transplantation: impact of immunosuppressive and antihypertensive therapy. Diabetes Care2001; 24: 2121–6.
7.
HillC.M., DouglasJ.F., RajkumarK.V.. Glycosuria and hyperglycaemia after kidney transplantation. Lancet1974; 2: 490–2.
8.
HjelmesaethJ., HartmannA., KofstadJ.. Tapering off prednisolone and cyclosporin the first year after renal transplantation: the effect on glucose tolerance. Nephrol Dial Transplant2001; 16: 829–35.
9.
BootsJ.M., van DuijnhovenE.M., ChristiaansM.H.. Glucose metabolism in renal transplant recipients on tacrolimus: the effect of steroid withdrawal and tacrolimus trough level reduction. J Am Soc Nephrol2002; 13: 221–7.
10.
MidtvedtK., HjelmesaethJ., HartmannA.. Insulin resistance after renal transplantation: the effect of steroid dose reduction and withdrawal. J Am Soc Nephrol2004; 15: 3233–9.
11.
WoodieE.S., FirstM.R., PirschJ.. A prospective, randomized, double blind, placebo controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long term, low dose corticosteroid therapy. Ann Surg2008; 248: 564–77.
12.
WoodwardR.S., SchnitzlerM.A., BatyJ.. Incidence and cost of new onset diabetes mellitus among U.S wait-listed and transplanted renal allograft recipients. Am J Transplant2003; 3: 590–8.
13.
VincentiF., FrimanS., ScheuermannE.. Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. Am J Transplant2007; 7: 1506–14.
14.
LuanF.L., ZhangH., SchaubelD.E.. Comparative risk of impaired glucose metabolism associated with cyclosporine versus tacrolimus in the late posttransplant period. Am J Transplant2008; 8: 1871–7.
15.
JohnstonO., RoseC.L., WebsterA.C.. Sirolimus is associated with new-onset diabetes in Kidney transplant recipients. J Am Soc Nephrol2008; 19: 1411–8.
16.
TeutonicoA., SchenaP.F., Di PaoloS.Glucose metabolism in renal transplant recipients: effect of calcineurin inhibitor withdrawal and conversion to sirolimus. J Am Soc Nephrol2005; 16: 3128–35.
17.
BloomR.D., CrutchlowM.E.New-Onset diabetes mellitus in the kidney recipient: diagnosis and management strategies. Clin J Am Soc Nephrol2008; 3(suppl): S38–S48.
18.
CosioF.G., KudvaY., van der VeldeM.. New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation. Kidney Int2005; 67: 2415–21.
19.
WilkinsonA., DavidsonJ., DottaF.. Guidelines for the treatment and management of new-onset diabetes after transplantation. Clin Transplant2005; 19: 291–8.
20.
American Diabetes Association: Standards of medical care in diabetes-2006. Diabetes Care2006; 29(Suppl 1): S4–S42.
